Pharmaceutical composition of curing endometriosis uterina
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of endometrium and composition, applied in the field of active ingredient composition of traditional Chinese medicine, can solve problems such as unsatisfactory curative effect, many side effects, and unclear pathogenesis of endometriosis
Inactive Publication Date: 2009-11-11
SOUTHWEST UNIVERSITY
View PDF0 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Since the etiology and pathogenesis of endometriosis are still unclear, there has been no mature plan and ideal treatment drugs. Most of them use
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0012] Embodiment 1 (1000 preparation units)
[0013] Ligustrazine 50g
[0014] Ferulic acid 100g
[0015] Corydalin 30g
[0016] Preparation method: the above three components are added to common pharmaceutical excipients, and prepared into injections, suppositories, aerosols, and transdermal preparations according to conventional methods.
Embodiment 2
[0017] Embodiment 2 (1000 preparation units)
[0018] Ligustrazine 500g
[0019] Ferulic acid 1000g
[0020] Tetrahydropalmatine 300g
[0021] Preparation method: The above three components are added with commonly used excipients in pharmacy, and prepared into pills, tablets, enteric-coated tablets, sustained-release tablets, controlled-release tablets, hard capsules, soft capsules, granules, drop pills, and micropills according to conventional methods.
Embodiment 3
[0022] Embodiment 3 (1000 preparation units)
[0023] Ligustrazine 2000g
[0024] Ferulic acid 4000g
[0025] Tetrahydropalmatine 1200g
[0026] Preparation method: the above three components are added to common pharmaceutical excipients, and prepared into oral solutions, oral suspensions, oral emulsions, syrups, etc. according to conventional methods.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000mg of ferulic acid (or sodium ferulate) as well as 30 to 1200mg of tetrahydropalmatine (or tetrahydropalmatine sulfate). The pharmaceutical composition also comprises pharmaceutically acceptable adjuvant which is prepared into any medicament form suitable to be used in clinic. The invention aims at the pathology of the endometriosis uterine and adopts the active components of Chinese herbs such as ligustrazine, ferulic acid and tetrahydropalmatine with reliable pathology effects to provide a novel pharmaceutical composition which can resist the vein hyperplasia of ectopic endometrium, reduce the level of estrogen, raise the level of progestational hormone, resist inflammatory, kill pain and adjust immunity, thereby realizing the treatment to the endometriosis uterine.
Description
technical field [0001] The invention relates to a traditional Chinese medicine active ingredient composition for treating endometriosis, which is characterized in that the pharmaceutical composition contains the following active ingredients: ligustrazine (or ligustrazine phosphate, ligustrazine hydrochloride), ferulic acid ( or sodium ferulate), the pharmaceutical composition of tetrahydropalmatine (or tetrahydropalmatine sulfate). Background technique [0002] Endometriosis is a common disease in women of childbearing age, which mainly causes infertility, dysmenorrhea, chronic pelvic pain and other symptoms, seriously affects women's health and quality of life, and is closely related to malignant tumors. One of the difficult diseases. Since the etiology and pathogenesis of endometriosis are still unclear, there has been no mature plan and ideal drug for treatment. Most of them are treated with compound oral contraceptives, progesterone, gestrinone and other drugs, which ha...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more